Four things to know:
1. The bill would require infants born in the state to be tested for genetic markers linked with SMA.
2. SMA is a rare genetic disease that leads to progressive muscle weakness and, in some cases, paralysis.
3. The FDA approved AveXis’ $2.1 million gene therapy drug Zolgensma for SMA in May, which The Washington Post reported to be the most expensive drug in the world.
4. The Senate returned a unanimous vote of 36-0 on the bill.
More articles on spine:
Johns Hopkins, Carrum partnership grows to spine surgery
New York spine surgeon sentenced to probation, house arrest — 4 insights
11 PE transactions in orthopedics in 2019
